Research and Development of Digestive Drugs for New Diseases is Expected to Propel the Growth of the Digestive System Drugs Market

The global digestive system drugs market is anticipated to grow at a considerable CAGR of 4.9% during the forecast period (2022-2028). Globally, the market for digestive system medications is anticipated to grow. Various practitioners and pharmaceutical firms have made significant investments, which will create growth prospects over the anticipated time as well as newly released medications can benefit people suffering from bowel syndrome, particularly those who are constipated. At the end of the anticipated time for the gastrointestinal medications market, high research and development in the pharmaceutical sector will create numerous growth chances. For instance, in August 2018 The European Union has given Pfizer Inc. clearance to market XELJANZ for the treatment of moderate to severe ulcerative colitis. Over the forecast period, the novel introduction of products from this strong pipeline is expected to boost the market growth.  For instance, in March 2019 STELARA was found to be effective in individuals with moderate to severe ulcerative colitis, according to fresh clinical data from Johnson & Johnson's Phase III UNIFI research.

Browse the full report description “Global Digestive System Drugs Market Size, Share & Trends Analysis Report by Drug Type (Antacids, Laxatives, Antidiarrheal, and Antiemetics), by Dosage Form (Oral and Parenteral), and by Application (Irritable Bowel Syndrome, Crohn’s Disease, Gastroenteritis, and Others) Forecast 2022-2028“at https://www.omrglobal.com/industry-reports/digestive-system-drugs-market

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Drug Type
• By Dosage Form
• By Application 

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- including Abbott Laboratories Pvt. Ltd., AstraZeneca Plc., Cipla Inc., Takeda Pharmaceuticals Co. Ltd., Valeant Pharmaceuticals Inc., and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Digestive System Drugs Market Report Segment

By Drug Type

• Antacids
• Laxatives
• Antidiarrheal
• Antiemetics

By Dosage Form

• Oral
• Parenteral

By Application

• Irritable Bowel Syndrome
• Crohn’s Disease
• Gastroenteritis
• Others (Ulcerative Colitis, Celiac Disease)

Global Digestive System Drugs Market Report Segment by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa